Summary by Moomoo AI
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. (Pharmaceutical Ming Kand) repurchased a total of 7,319,317 A-shares through the Shanghai Stock Exchange between March 11 and April 8, 2024. The Company's share repurchase operation began on March 11, 2024, with a first repurchase of 937,079 shares and a final repurchase of 434,846 shares on April 8, with a repurchase price of RMB 45.78 to RMB 57.32 per share. Pursuant to the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company filed a next-day disclosure statement with the Stock Exchange on 8 April, disclosing the changes in issued share capital. The share repurchase of the series did not involve a share write-off and was formally presented by Mr. Li Keung, the Company's director.